Eroxon® Stimgel has been certified under EU Regulation 2017/745 (the “MDR”), as a treatment of erectile dysfunction. It is classed as a medical device, not a drug, because it works through physical, not chemical means.
As a CE-marked medical device, meaning it meets the safety, health and environmental protection requirements of the EU, Eroxon® Stimgel may be marketed throughout the EEA. It is also approved in the UK as a medical device.